Why is Novo Nordisk suing Hims & Hers?

Novo Nordisk is suing Hims & Hers because the telehealth company announced plans to offer compounded copies of Novo Nordisk's Wegovy pill, which Novo Nordisk alleges is illegal and poses risks to patient safety.

What is Hims & Hers offering?

Hims & Hers announced it will begin offering a compounded version of Novo Nordisk's Wegovy pill at an introductory price of $49 per month.

What is Novo Nordisk's stance on compounded Wegovy copies?

Novo Nordisk considers the compounded copies illegal mass compounding and states it poses significant risks to patient safety, vowing to take legal and regulatory action.

Home / Business and Economy / Novo Nordisk Sues Hims & Hers Over Wegovy Knockoff

Novo Nordisk Sues Hims & Hers Over Wegovy Knockoff

5 Feb

•

Summary

Novo Nordisk is suing Hims & Hers for offering compounded Wegovy copies.
Hims & Hers plans to offer a compounded version for $49 monthly.
Novo Nordisk cites patient safety and intellectual property risks.

Novo Nordisk Sues Hims & Hers Over Wegovy Knockoff

Novo Nordisk is initiating legal proceedings against Hims & Hers, an online telehealth provider. This action follows Hims & Hers' announcement that it will offer a compounded version of the popular Wegovy pill.

Hims & Hers intends to market this compounded drug at an introductory price of $49 per month. Novo Nordisk has strongly condemned this move, labeling it as "illegal mass compounding" that poses serious threats to patient safety. The company has vowed to pursue legal and regulatory measures.

Novo Nordisk emphasized its role as the sole manufacturer of the FDA-approved oral Wegovy, formulated with proprietary SNAC technology to enhance semaglutide absorption. The company aims to safeguard patients, its intellectual property, and the established drug approval system.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.